Monday, Jan 12, 2026 · SEC filings
What the smart money revealed on Jan 12
433 insider filings came in. We hid 50 planned (10b5-1) sellers and 299 people whose filings were routine, like grants and tax withholding.
Aktis Oncology (AKTS) Director Oleg Nodelman bought $40M
2.22M shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 3 checked quarters beat the typical stock 6 months later.
Aktis Oncology (AKTS) Director Helen Kim bought $15M
835,000 shares on the open market. Not a grant or an option exercise.
Alumis (ALMS) Director James Tananbaum bought $7M
411,764 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 3 checked quarters beat the typical stock 6 months later.
Agree Realty (ADC) Executive Chairman of Board Richard Agree bought $1.7M
24,000 shares on the open market. Not a grant or an option exercise.
Diversified Energy (DEC) Director Randall Wade sold $27.9M
Not marked as a planned 10b5-1 sale. Sold 22% of the shares they held directly. Still holds 7.5M shares.
AAR (AIR) Senior Vice President-CCO Christopher Jessup sold $2.29M
Not marked as a planned 10b5-1 sale. Sold 26% of the shares they held directly. Still holds 65,769 shares.
Netskope (NTSK) Chief Revenue Offucer Raphael Bousquet sold $171K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 26 more real buys
Show 31 more real sales
13F season
Holdings as of Dec 31, 2025 are due Feb 17
320 funds have filed so far. 81 filed for the quarter before.
Biggest real insider buys this week
Open-market buys by officers and directors, filed in the 7 days up to Jan 12.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.